Jane Street
VNDA icon

Jane Street’s Vanda Pharmaceuticals VNDA Stock Holding History

Jane Street’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-24,100
Closed -$413K – 10857
2021
Q3 		$413K Buy
24,100
+11,600
+93% +$203K ﹤0.01% 7629
2021
Q2 		$269K Buy
+12,500
New +$224K ﹤0.01% 8343
2018
Q2 		– Sell
-17,400
Closed -$293K – 5671
2018
Q1 		$293K Buy
+17,400
New +$291K ﹤0.01% 4051

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's VNDA Position: Q2 2026 in Review

Jane Street sold out of Vanda Pharmaceuticals (VNDA) in Q2 2026, closing a stake of 210,243 shares — an estimated $1.45M sold.

Jane Street first reported a position in VNDA in Q1 2014 and held it in 26 quarters. The position peaked at $1.45M in Q1 2026. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Jane Street reported no remaining Vanda Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 210,243 Vanda Pharmaceuticals shares in Q2 2026, an estimated $1.45M.
  • Jane Street first reported a position in Vanda Pharmaceuticals in Q1 2014 and held it in 26 quarters.
  • Jane Street's Vanda Pharmaceuticals position peaked at $1.45M in Q1 2026.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.